REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 140 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,479,800 | +3.5% | 53,461 | 0.0% | 0.01% | +9.1% |
| Q2 2023 | $1,430,082 | +44.9% | 53,461 | +17.3% | 0.01% | +57.1% |
| Q1 2023 | $987,176 | +4.9% | 45,576 | +15.3% | 0.01% | 0.0% |
| Q4 2022 | $941,295 | +20.8% | 39,517 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $779,275 | +16.7% | 39,517 | +15.4% | 0.01% | +40.0% |
| Q2 2022 | $667,649 | -23.6% | 34,256 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $873,871 | +60.6% | 34,256 | +58.5% | 0.01% | +20.0% |
| Q4 2021 | $543,999 | -8.5% | 21,613 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $594,574 | -13.3% | 21,613 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $685,997 | -10.2% | 21,613 | +29.8% | 0.01% | 0.0% |
| Q1 2021 | $764,223 | +15.9% | 16,657 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $659,451 | +13.8% | 16,657 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $579,664 | +161.9% | 16,657 | +137.5% | 0.01% | +100.0% |
| Q2 2020 | $221,369 | +44.1% | 7,012 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $153,633 | – | 7,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |